HTB

Early access

Leading SARS-CoV-2 antibody tests meet specificity but fail current sensitivity guidelines

Neural tube defects in two of 1000 conception exposures with dolutegravir: reassuring update from Tsepamo study

HepC drugs work against COVID-19: faster recovery and reduced mortality from generic sofosbuvir and daclatasvir

New HIV remission case report at AIDS 2020: full report

AIDS2020 online: introduction

Case report of short-term HIV remission from adding oral nicotinamide to intensified ART

Dolutegravir associated with weight gain in African ART programmes: findings from AFRICOSĀ 

Individualising management of COVID-19 based on real-time inflammatory responses

Pneumocystis Jirovecii Pneumonia (PJP) mistaken for COVID-19 in late stage undiagnosed: urgency of including HIV testing on admission

Hydroxychloroquine and lopinavir/r arms stopped in the WHO SOLIDARITY study

FDA approves fostemsavir for multidrug resistant HIV in the US

RECOVERY study reports that lopinavir/r fails to show benefit against COVID-19

EMA grants conditional approval for remdesivir in the EU to treat COVID-19

FDA guidance on COVID-19 vaccine includes minimal target of 50% efficacy

HTB 30 September 2019 online

29 March 2019: vol 20 no 4 – second CROI reports